Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience
Lazaro M Filgueira, Armando Caballero, Julio L. Betancourt, C. Hidalgo, Naivy Sanchez, Ariam Senrra, Delvis González, Yaumara Aguilera, Geidy Lorenzo, Meylán Cepeda, Danay Saavedra, Ana Laura Ane, Irinia Valdivia, Carmen Valenzuela, Patricia Lorenzo Luaces, Zaima Mazorra, Mayra Ramos, Kalet León, Tania Crombet (2022). Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience. , 06(03), DOI: https://doi.org/10.26502/acmcr.96550496.
Article60 days agoAn Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases
Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Marcelo Figueredo, Jorge A. Caballero, Naivy Sánchez, Jorge Berrio, Geidy Lorenzo, Meylán Cepeda, Mayra Ramos, Danay Saavedra, Ana Laura Añé-Kourí, Zaima Mazorra, Kalet León, Tania Crombet, Armando Caballero (2021). An Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases. , 13(4), DOI: https://doi.org/10.2217/imt-2020-0235.
Article60 days agoTreatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab
Armando Caballero, Lázaro Manuel Filgueira, J. R. Betancourt, Naivy Sánchez, Carlos Hidalgo, Alberto Ramírez, Alejandro Gallego Martínez, Rolando E Despaigne, Alberto Escalona, Henrry Diaz, Elio Meriño, Lilia M Ortega, Ulises Castillo, Mayra Ramos, Danay Saavedra, Y. Fernandez Garcia, Geydi Lorenzo, Meylán Cepeda, Maylén Arencibia, Leticia Cabrera, Milagros Domecq, Daymys Estévez, Carmen Valenzuela, Patricia Lorenzo, Lizet Sánchez, Zaima Mazorra, Kalet León, Tania Crombet (2020). Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab. , 9(11), DOI: https://doi.org/10.1002/cti2.1218.
Article60 days agoAn anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, J. R. Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, Carlos Hidalgo, Geydi Lorenzo, Meylán Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet (2020). An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients. , 17(1), DOI: https://doi.org/10.1186/s12979-020-00207-8.
Article60 days agoUse of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19
Yayquier Díaz, Mayra Ramos, Yordanis Martín, Néstor Antonio Calderón, William Santiago, Orlando Viñet, Yulieski La O, Jorge Pérez Augusto Oyarzábal, Yoan Pérez, Geidy Lorenzo, Meylán Cepeda, Danay Saavedra, Zaima Mazorra, Daymys Estévez, Patricia Lorenzo-Luaces, Carmen Valenzuela, Armando Caballero, Kalet León, Tania Crombet, Carlos Jorge Hidalgo (2020). Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19. , 66(6), DOI: https://doi.org/10.1159/000512210.
Article60 days ago